Taro is a research-based international pharmaceutical company that was established on the principle that research and development would be the cornerstone of its growth strategy.

Providing quality products through scientific innovations, diligence and precision is the goal of all of Taro's research programs.

Taro develops, manufactures and markets affordable prescription and over-the counter medications.

Healthcare Professionals - Taro RX

Consumers or Patients - Taro OTC

More details about Taro Canada Products please Click Here

Introducing Tarocares.ca: our new patient support hub intended for healthcare professionals and patients who have been prescribed a Taro specialty product.

Click below for more information and a list of covered medications.

More details about Taro Canada Products please Click Here

The Taro Canada Customer Service department is passionately committed to providing an exceptional level of service through our attention to detail and a thorough understanding of our customers ever changing needs.

More details about Customer Services please Click Here

Resources to support many Taro products are available for download.

These tools can be viewed online, printed, or paper copies can be requested by contacting the Taro Canada Customer Service department.

More details about Taro Canada Products please Click Here

All RAN-labeled products will be changing to the Taro label.

For the majority of products only the prefix will change, RAN will become TARO. Product markings, formulations, DINs and UPC numbers will remain the same.

Check here for the most up to date information on RAN-to-TARO label changes.

More details about Taro Canada Products please Click Here

Taro embraces diversity in the workplace and is committed to achieving employment equity. Our goal is to attract, develop and retain highly talented employees from diverse backgrounds, allowing us to benefit from a wide variety of experiences and perspectives.

More details about Career Opportunities please Click Here
News Updates
  • September 2024

    Now available, Taro-Palbociclib, a generic alternative to Ibrance®

  • May 2024

    Now available, Taro-Fusidic Acid, the first Canadian generic...

  • April 2024

    Now available, Taro-Posaconazole, a generic alternative to Posanol®

More News
PRODUCT LAUNCH More
TARO-PALBOCICLIB, Immediate-Release Tablets